Clinical phenotype and immunological features of a patient with A20 haploinsufficiency

Objective: To explore the clinical phenotype, immunological features, pathogenesis and gene variation of a case with A20 haploinsufficiency (HA20). Methods: A patient diagnosed with tumor necrosis factor α-induced protein 3 (TNFAIP3) mutated HA20 was admitted into Shenzhen Children's Hospital i...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 58(2020), 3 vom: 02. März, Seite 218-222
1. Verfasser: Huang, Y Y (VerfasserIn)
Weitere Verfasser: He, T Y, Xia, Y, Luo, Y, Weng, R H, Luo, S L, Yang, J, Zhao, X D
Format: Online-Aufsatz
Sprache:Chinese
Veröffentlicht: 2020
Zugriff auf das übergeordnete Werk:Zhonghua er ke za zhi = Chinese journal of pediatrics
Schlagworte:Case Reports Journal Article Genes Haploinsufficiency Mutation NF-kappa B TNFAIP3 protein, human EC 3.4.19.12 Tumor Necrosis Factor alpha-Induced Protein 3
LEADER 01000naa a22002652 4500
001 NLM307265765
003 DE-627
005 20231225125205.0
007 cr uuu---uuuuu
008 231225s2020 xx |||||o 00| ||chi c
024 7 |a 10.3760/cma.j.issn.0578-1310.2020.03.011  |2 doi 
028 5 2 |a pubmed24n1024.xml 
035 |a (DE-627)NLM307265765 
035 |a (NLM)32135594 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Huang, Y Y  |e verfasserin  |4 aut 
245 1 0 |a Clinical phenotype and immunological features of a patient with A20 haploinsufficiency 
264 1 |c 2020 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 16.03.2020 
500 |a Date Revised 16.03.2020 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Objective: To explore the clinical phenotype, immunological features, pathogenesis and gene variation of a case with A20 haploinsufficiency (HA20). Methods: A patient diagnosed with tumor necrosis factor α-induced protein 3 (TNFAIP3) mutated HA20 was admitted into Shenzhen Children's Hospital in May,2019.The clinical data was analyzed. Flow cytometry was used to detect the patient's peripheral blood lymphocyte subsets, and also, the percentage of follicular helper T cell (TFH) cells in the patient and thirteen healthy controls. After the construction of empty vector, wild-type and mutant plasmid vectors, a wild-type or mutant overexpression system of the TNFAIP3 gene was established in 293T cells and Hela cells. Then, the expression level of A20 in 293T cells and the expression of inhibitor K binding α (IKBα) in green fluorescent protein (GFP)+Hela cells before and after tumor necrosis factor α (TNF-α) stimulation were measured, to verify the pathogenicity of this variation. Results: A 5 years and 11 months old boy, presented with recurrent oral ulcer, abdominal pain, joint swelling and arthralgia. Oral ulcer, chronic skin rashes, knee joint swelling were observed. The levels of inflammatory markers were increased. Colonoscopy showed congestion of mucosa and multiple ulcers in terminal ileum and ileocecus. The absolute number of naive B cells was 124×10(6) cells/L (reference range 147×10(6)-431×10(6) cells/L), accounting for 0.430 of the total B cells (reference range 0.484-0.758). Compared to healthy controls (0.016-0.071), the percentage of TFH cells in CD4(+)T cells was much lower (0.008).A heterozygous mutation of TNFAIP3 gene (c.909_913 del, p.L303fs) was identified by genetic analysis. In vitro study showed that truncated A20 protein was expressed in TNFAIP3 mutant overexpressed 293T cells, which verified the pathogenicity of this variation. Besides, after TNF-α stimulation, the degradation rate of IkBα protein in mutant overexpressed Hela cells (35%) was between the other two groups (15% in the wild-type group and 57% in the non-loaded group). Conclusions: This case with HA20 due to a de novo TNFAIP3 gene mutation presents with early onset Behcet-like autoinflammatory syndrome. This variation leads to expression of truncated A20 protein, enhanced degradation of IkBα, and further activation of nuclear factor κB signaling pathway 
650 4 |a Case Reports 
650 4 |a Journal Article 
650 4 |a Genes 
650 4 |a Haploinsufficiency 
650 4 |a Mutation 
650 7 |a NF-kappa B  |2 NLM 
650 7 |a TNFAIP3 protein, human  |2 NLM 
650 7 |a EC 3.4.19.12  |2 NLM 
650 7 |a Tumor Necrosis Factor alpha-Induced Protein 3  |2 NLM 
650 7 |a EC 3.4.19.12  |2 NLM 
700 1 |a He, T Y  |e verfasserin  |4 aut 
700 1 |a Xia, Y  |e verfasserin  |4 aut 
700 1 |a Luo, Y  |e verfasserin  |4 aut 
700 1 |a Weng, R H  |e verfasserin  |4 aut 
700 1 |a Luo, S L  |e verfasserin  |4 aut 
700 1 |a Yang, J  |e verfasserin  |4 aut 
700 1 |a Zhao, X D  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhonghua er ke za zhi = Chinese journal of pediatrics  |d 1960  |g 58(2020), 3 vom: 02. März, Seite 218-222  |w (DE-627)NLM136249191  |x 0578-1310  |7 nnns 
773 1 8 |g volume:58  |g year:2020  |g number:3  |g day:02  |g month:03  |g pages:218-222 
856 4 0 |u http://dx.doi.org/10.3760/cma.j.issn.0578-1310.2020.03.011  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_61 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_244 
912 |a GBV_ILN_285 
912 |a GBV_ILN_294 
912 |a GBV_ILN_350 
912 |a GBV_ILN_665 
912 |a GBV_ILN_813 
951 |a AR 
952 |d 58  |j 2020  |e 3  |b 02  |c 03  |h 218-222